EE200200116A - Leptiini või selle homoloogi või derivaadi kasutamine, farmatseutiline kompositsioon ja segu - Google Patents

Leptiini või selle homoloogi või derivaadi kasutamine, farmatseutiline kompositsioon ja segu

Info

Publication number: EE200200116A
Authority: EE; Estonia
Prior art keywords: leptin; homologue; derivative; mixture; pharmaceutical composition
Prior art date: 1999-09-05

Application number

EEP200200116A

Other languages

English (en)

Inventor

Rubinstein Menachem

Cohen Batya

Barkan Dalit

Original Assignee

Yeda Research And Development Co. Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-05

Filing date

2000-09-04

Publication date

2003-04-15

1999-09-05 Priority claimed from IL13173999A external-priority patent/IL131739A0/xx

2000-09-04 Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.

2003-04-15 Publication of EE200200116A publication Critical patent/EE200200116A/et

2010-02-15 Publication of EE05262B1 publication Critical patent/EE05262B1/et

Links

102000016267 Leptin Human genes 0.000 title 1
108010092277 Leptin Proteins 0.000 title 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title 1
229940039781 leptin Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Obesity (AREA)
Zoology (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Genetics & Genomics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EEP200200116A 1999-09-05 2000-09-04 Leptiini v?i selle homoloogi v?i derivaadi kasutamine, farmatseutiline kompositsioon ja segu EE05262B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL13173999A IL131739A0 (en)	1999-09-05	1999-09-05	Use of leptin in inhibition of endothelial cell proliferation
IL13231299A IL132312A0 (en)	1999-09-05	1999-10-10	Use of leptin in inhibition of endothelial cell proliferation
PCT/IL2000/000525 WO2001018040A2 (en)	1999-09-05	2000-09-04	Use of leptin in inhibition of endothelial cell proliferation

Publications (2)

Publication Number	Publication Date
EE200200116A true EE200200116A (et)	2003-04-15
EE05262B1 EE05262B1 (et)	2010-02-15

Family

ID=26323878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200116A EE05262B1 (et)	1999-09-05	2000-09-04	Leptiini v?i selle homoloogi v?i derivaadi kasutamine, farmatseutiline kompositsioon ja segu

Country Status (19)

Country	Link
EP (1)	EP1210108B1 (et)
JP (1)	JP2003508544A (et)
KR (1)	KR100683362B1 (et)
CN (1)	CN1189479C (et)
AR (1)	AR025494A1 (et)
AT (1)	ATE449609T1 (et)
AU (1)	AU781390B2 (et)
BR (1)	BR0013778A (et)
CA (1)	CA2382941C (et)
DE (1)	DE60043391D1 (et)
EA (1)	EA005066B1 (et)
EE (1)	EE05262B1 (et)
ES (1)	ES2335569T3 (et)
HK (1)	HK1048075B (et)
IL (1)	IL132312A0 (et)
MX (1)	MXPA02002448A (et)
NO (1)	NO325989B1 (et)
UA (1)	UA74163C2 (et)
WO (1)	WO2001018040A2 (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355237B1 (en) *	1994-09-14	2002-03-12	Progenitor, Inc.	Methods for using the obese gene and its gene product to stimulate hematopoietic development
US8633250B2 (en) *	2006-01-12	2014-01-21	Musc Foundation For Research Development	Cell repair and regeneration by suramin and related polysulfonated napthylureas
KR20120064067A (ko)	2009-06-17	2012-06-18	고꾸리쯔다이가꾸호오진 구마모또 다이가꾸	월경곤란증의 예방 및/또는 치료약

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69735477T2 (de) *	1996-01-23	2006-11-30	Indevus Pharmaceuticals, Inc., Lexington	Process zur verwendung des obese-gens und seines genprodukts zur stimulierung der entwicklung von haemotopoietischen zellen
IT1288388B1 (it) *	1996-11-19	1998-09-22	Angeletti P Ist Richerche Bio	Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
IL120733A0 (en) *	1997-04-29	1997-08-14	Yeda Res & Dev	Leptin as an inhibitor of cell proliferation
AU4672199A (en) *	1998-05-20	1999-12-06	Yale University	Modulation of angiogenesis and wound healing

1999
- 1999-10-10 IL IL13231299A patent/IL132312A0/xx unknown
2000
- 2000-04-09 UA UA2002042717A patent/UA74163C2/uk unknown
- 2000-09-04 AT AT00956758T patent/ATE449609T1/de not_active IP Right Cessation
- 2000-09-04 BR BR0013778-2A patent/BR0013778A/pt not_active Application Discontinuation
- 2000-09-04 ES ES00956758T patent/ES2335569T3/es not_active Expired - Lifetime
- 2000-09-04 WO PCT/IL2000/000525 patent/WO2001018040A2/en not_active Ceased
- 2000-09-04 CN CNB00813748XA patent/CN1189479C/zh not_active Expired - Fee Related
- 2000-09-04 EE EEP200200116A patent/EE05262B1/et not_active IP Right Cessation
- 2000-09-04 AU AU68620/00A patent/AU781390B2/en not_active Ceased
- 2000-09-04 CA CA2382941A patent/CA2382941C/en not_active Expired - Fee Related
- 2000-09-04 KR KR1020027002112A patent/KR100683362B1/ko not_active Expired - Fee Related
- 2000-09-04 AR ARP000104622A patent/AR025494A1/es unknown
- 2000-09-04 JP JP2001522262A patent/JP2003508544A/ja active Pending
- 2000-09-04 HK HK03100442.1A patent/HK1048075B/zh not_active IP Right Cessation
- 2000-09-04 EA EA200200331A patent/EA005066B1/ru not_active IP Right Cessation
- 2000-09-04 DE DE60043391T patent/DE60043391D1/de not_active Expired - Lifetime
- 2000-09-04 MX MXPA02002448A patent/MXPA02002448A/es active IP Right Grant
- 2000-09-04 EP EP00956758A patent/EP1210108B1/en not_active Expired - Lifetime
2002
- 2002-02-25 NO NO20020920A patent/NO325989B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL132312A0 (en)	2001-03-19
CA2382941A1 (en)	2001-03-15
UA74163C2 (uk)	2005-11-15
BR0013778A (pt)	2002-05-14
WO2001018040A2 (en)	2001-03-15
NO20020920D0 (no)	2002-02-25
EP1210108B1 (en)	2009-11-25
EP1210108A2 (en)	2002-06-05
ATE449609T1 (de)	2009-12-15
CN1377277A (zh)	2002-10-30
ES2335569T3 (es)	2010-03-30
DE60043391D1 (de)	2010-01-07
EA005066B1 (ru)	2004-10-28
JP2003508544A (ja)	2003-03-04
EE05262B1 (et)	2010-02-15
KR100683362B1 (ko)	2007-02-15
AU6862000A (en)	2001-04-10
MXPA02002448A (es)	2002-07-30
KR20020040781A (ko)	2002-05-30
AR025494A1 (es)	2002-11-27
HK1048075A1 (en)	2003-03-21
CA2382941C (en)	2011-08-16
HK1048075B (zh)	2005-07-29
EA200200331A1 (ru)	2002-08-29
NO325989B1 (no)	2008-09-01
NO20020920L (no)	2002-05-03
CN1189479C (zh)	2005-02-16
AU781390B2 (en)	2005-05-19
WO2001018040A3 (en)	2001-06-14

Publication	Publication Date	Title
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE04275B1 (et)	2004-04-15	Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE200300145A (et)	2003-06-16	Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
FI20000677A7 (fi)	2000-09-30	Oksiimijohdannaiset ja niiden käyttö latentteina happoina
EE05104B1 (et)	2008-12-15	Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
EE200100391A (et)	2002-10-15	Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
EE200100022A (et)	2002-06-17	Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
EE9900018A (et)	1999-08-16	Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
EE200200251A (et)	2003-06-16	Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE04717B1 (et)	2006-10-16	Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE04497B1 (et)	2005-06-15	Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE04015B1 (et)	2003-04-15	Asendatud 2,4-tiasolidiindiooni derivaadid, nendevalmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE9900112A (et)	1999-10-15	2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200000226A (et)	2001-06-15	3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE200100314A (et)	2002-08-15	Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
EE9900034A (et)	1999-08-16	Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
EE05004B1 (et)	2008-04-15	Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200100173A (et)	2002-08-15	2-fenüülpüraan-4-ooni derivaadid, nende valmistamismeetod ja kasutamine, vaheühendite kasutamine jafarmatseutiline kompositsioon
BR0012184B1 (pt)	2013-09-24	compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
EE200100051A (et)	2002-06-17	Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
EE03996B1 (et)	2003-04-15	Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE04770B1 (et)	2007-02-15	Tritsüklilised delta3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2014-06-16	MM4A	Lapsed by not paying the annual fees	Effective date: 20130904